CCM
RYTM icon

Cinctive Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Cinctive Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,225
Closed -$345K – 493
2025
Q4 		$345K Sell
3,225
-31,931
-91% -$3.39M 0.02% 350
2025
Q3 		$3.55M Sell
35,156
-35,781
-50% -$3.32M 0.17% 185
2025
Q2 		$4.48M Buy
70,937
+66,581
+1,528% +$4.08M 0.24% 143
2025
Q1 		$231K Sell
4,356
-78,399
-95% -$4.35M 0.02% 295
2024
Q4 		$4.63M Buy
+82,755
New +$4.57M 0.24% 140

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Cinctive Capital Management's RYTM Position: Q1 2026 in Review

Cinctive Capital Management sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 3,225 shares — an estimated $345K sold.

Cinctive Capital Management first reported a position in RYTM in Q4 2024 and held it in 5 quarters. The position peaked at $4.63M in Q4 2024. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Cinctive Capital Management reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 3,225 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $345K.
  • Cinctive Capital Management first reported a position in Rhythm Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Cinctive Capital Management's Rhythm Pharmaceuticals position peaked at $4.63M in Q4 2024.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.